Schwannomatosis
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis (NCT04163419) | Massachusetts General Hospital | 2020-04-30 |
| Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype (NCT02298270) | Massachusetts General Hospital | 2014-03-01 |
| Neurofibromatosis (NF) Registry Portal (NCT01885767) | The Children's Tumor Foundation | 2012-06-01 |
Track Schwannomatosis automatically
Every clearance here is in the API, with alerts when new ones post.